Analyst ratings and price targets can significantly influence a company's stock price. In this case, Deutsche Bank, a reputable financial institution, has given Autolus Therapeutics a Buy rating and set a price target of $10. This suggests that they believe the company's stock is undervalued and has potential for growth, which could encourage investors to buy the stock and drive up its price in the short term.